HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells.

AbstractAIM:
To evaluate the safety and clinical efficacy of a new immunotherapy using both α-Gal epitope-pulsed dendritic cells (DCs) and cytokine-induced killer cells.
METHODS:
Freshly collected hepatocellular carcinoma (HCC) tumor tissues were incubated with a mixture of neuraminidase and recombinant α1,3-galactosyltransferase (α1,3GT) to synthesize α-Gal epitopes on carbohydrate chains of the glycoproteins of tumor membranes. The subsequent incubation of the processed membranes in the presence of human natural anti-Gal IgG resulted in the effective phagocytosis to the tumor membrane by DCs. Eighteen patients aged 38-78 years with stage III primary HCC were randomLy chosen for the study; 9 patients served as controls, and 9 patients were enrolled in the study group.
RESULTS:
The evaluation demonstrated that the procedure was safe; no serious side effects or autoimmune diseases were observed. The therapy significantly prolonged the survival of treated patients as compared with the controls (17.1 ± 2.01 mo vs 10.1 ± 4.5 mo, P = 0.00121). After treatment, all patients in the study group had positive delayed hypersensitivity and robust systemic cytotoxicity in response to tumor lysate as measured by interferon-γ-expression in peripheral blood mononuclear cells using enzyme-linked immunosorbent spot assay. They also displayed increased numbers of CD8-, CD45RO- and CD56-positive cells in the peripheral blood and decreased α-fetoprotein level in the serum.
CONCLUSION:
This new tumor-specific immunotherapy is safe, effective and has a great potential for the treatment of tumors.
AuthorsYing Qiu, Ming-Bao Xu, Mark M Yun, Yi-Zhong Wang, Rui-Ming Zhang, Xing-Kai Meng, Xiao-Hui Ou-Yang, Sheng Yun
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 17 Issue 48 Pg. 5260-6 (Dec 28 2011) ISSN: 2219-2840 [Electronic] United States
PMID22219594 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Epitopes
  • Glycoproteins
  • Galactosyltransferases
  • N-acetyllactosaminide alpha-1,3-galactosyltransferase
Topics
  • Adult
  • Aged
  • Antigens, Neoplasm (chemistry, immunology)
  • Carcinoma, Hepatocellular (drug therapy, immunology, pathology, therapy)
  • Cytokine-Induced Killer Cells (cytology, drug effects, immunology)
  • Dendritic Cells (cytology, drug effects, immunology)
  • Epitopes (immunology)
  • Female
  • Galactosyltransferases (genetics, metabolism)
  • Glycoproteins (chemistry, immunology)
  • Humans
  • Immunotherapy (methods)
  • Kaplan-Meier Estimate
  • Liver Neoplasms (drug therapy, immunology, pathology, therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: